Cheryl Hendrickson
Dados Biográficos
| ID | 7793413 |
|---|---|
| NOME | Cheryl Hendrickson |
| PRENOMES | Cheryl |
| SOBRENOME | Hendrickson |
| ASSINATURA | HENDRICKSON C |
| AFILIAÇÕES | University of the Witwatersrand |
| ORCID | 0000-0002-2744-5208 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2019 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Long-acting HIV pre-exposure prophylaxis integrated with community-based sexual and reproductive health services in South Africa (Lapis)
ClinicalTrials.gov Identifier-NCT06250504. Registered: 01 February 2024
Thetha Nami ngithethe nawe (Let’s Talk)
ClinicalTrials.gov Identifier-NCT05405582. Registered: 6th June 2022
The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention option, but cost-effectiveness is sensitive to implementation and program costs. Studies indicate that, in addition to direct delivery cost, PrEP provision requires substantial demand creation and client support to encourage PrEP initiation and persistence. We estimated the cost of providing PrEP in Zambia through different PrEP delivery models. Taking a guidelines-based approach for …
“Even if you’re HIV-positive there’s life after if you take your medication”
South Africa's national antiretroviral treatment (ART) programme, initiated in 2004, is the largest HIV treatment programme in the world with an estimated 4.2 million people on ART. Today, an HIV diagnosis is no longer associated with certain death, but is rather a manageable chronic disease, with all HIV-positive patients now eligible to receive treatment. In this study, we explore patient experiences at the onset of the ART programme, including…
Sem obras proeminentes nesta página.
“Even if you’re HIV-positive there’s life after if you take your medication”
South Africa's national antiretroviral treatment (ART) programme, initiated in 2004, is the largest HIV treatment programme in the world with an estimated 4.2 million people on ART. Today, an HIV diagnosis is no longer associated with certain death, but is rather a manageable chronic disease, with all HIV-positive patients now eligible to receive treatment. In this study, we explore patient experiences at the onset of the ART programme, including…
The early-stage comprehensive costs of routine PrEP implementation and scale-up in Zambia
Pre-exposure prophylaxis (PrEP) is an effective HIV prevention option, but cost-effectiveness is sensitive to implementation and program costs. Studies indicate that, in addition to direct delivery cost, PrEP provision requires substantial demand creation and client support to encourage PrEP initiation and persistence. We estimated the cost of providing PrEP in Zambia through different PrEP delivery models. Taking a guidelines-based approach for …
Thetha Nami ngithethe nawe (Let’s Talk)
ClinicalTrials.gov Identifier-NCT05405582. Registered: 6th June 2022
Long-acting HIV pre-exposure prophylaxis integrated with community-based sexual and reproductive health services in South Africa (Lapis)
ClinicalTrials.gov Identifier-NCT06250504. Registered: 01 February 2024
HIV/AIDS Research and Interventions (4 obras) · Family medicine (3 obras) · Medicine (3 obras) · Adolescent Sexual and Reproductive Health (2 obras) · Biostatistics (2 obras) · Cluster (spacecraft (2 obras) · Cluster randomised controlled trial (2 obras) · HIV, Drug Use, Sexual Risk (2 obras) · Nursing (2 obras) · Psychiatry (2 obras)